AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: target discoveryClear filter
opinionKavout

AI in Genomics Is Emerging as Drug Discovery’s Next Big Lever

A new commentary argues that AI in genomics may be the next major frontier for drug discovery. The thesis is compelling because genomics can provide the biological context AI needs to move from pattern recognition to more meaningful therapeutic insight. If that convergence matures, it could improve target identification, patient stratification, and precision medicine strategies.

genomicsAI drug discoveryprecision medicinetarget discovery
research

AI Tool Could Accelerate the Search for New Cancer Drug Targets

Dana-Farber Cancer Institute says a new AI tool could speed the discovery of cancer drug targets. The work adds to a growing body of evidence that AI is becoming more useful upstream, where it can help prioritize biology before expensive experimentation begins.

Dana-Farber Cancer Institute
cancer researchdrug targetsoncology
research

St. Jude says AI helped identify IRS4 as a promising tumor target across multiple solid cancers

Researchers at St. Jude report that an AI-assisted approach identified IRS4 as a promising drug target in several solid tumors. The finding highlights how AI is increasingly being used not just to analyze known disease biology, but to surface cross-cancer targets with translational potential.

St. Jude Children's Research Hospital
St. Judecancertarget discovery
research

AI Model That 'Reads' Protein Pairs Could Unlock New Drug Targets

A new AI model that interprets protein pairs may help researchers better understand disease biology and identify new targets. The advance highlights how protein interaction mapping is becoming a key frontier for AI in biomedical research.

Phys.org
proteinstarget discoveryprotein interactions
industry

Insilico’s Target Discovery Framework Points to a More Measurable AI Drug Pipeline

Insilico Medicine says its TargetPro–TargetBench framework has been validated for AI-driven target discovery. The announcement is notable because drug-discovery AI is increasingly being judged on measurable pipeline performance rather than broad platform claims.

Insilico Medicine
drug discoverytarget discoverybiotech AI
research

Why AI Is Becoming a Core Tool in Cancer Drug Discovery

Cancer research is emerging as one of the clearest use cases for AI in drug discovery because the search space is immense and biologically complex. The promise is not just faster screening, but better prioritization of targets and mechanisms that matter.

News-Medical
canceroncologydrug discovery

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.